Abstract
<h3>PURPOSE OF STUDY</h3> THIS STUDY is an analysis of 1,667 cases of scarlet fever observed over a period of fifteen months (April 1944 to June 1945), 466 cases in a civilian hospital for communicable diseases (Willard Parker Hospital, New York) and 1,201 cases in the contagious disease unit of an institution under military control (United States Public Health Service, Sheepshead Bay, N. Y.). The object is to evaluate the effects of gamma globulin as compared with the effects of four other therapeutic agents in scarlet fever—sulfadiazine, human scarlet fever immune serum, scarlet fever streptococcus antitoxin and symptomatic therapy only. Gamma globulin,<sup>1</sup>which is the immune globulin fraction of pooled human plasma, is best known at present because of its established worth in the prophylaxis of measles. Other clinical uses for this biologic preparation have been indicated through extensive laboratory investigations and have been the subject of intensive study in
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
